Accepting New Patients
Online Booking
Telehealth
Mauresa Walker, MD
Internal Medicine
Atlantic Medical Group
Speaks: Spanish
Female
Want to know your insurance options?
See Full ListMy upcoming availability
For existing patients
Use MyChart to schedule if you've seen this provider in the last 3 years.
About me
Dr. Mauresa Walker is board-certified in internal medicine and a physician with Healthfirst Associates, part of Atlantic Medical Group. Compassionate and personable, Dr. Walker strives to educate patients about preventative measures to promote overall health. She works with adults of all ages to manage chronic illness or recently diagnosed conditions such as diabetes, COPD and asthma. A graduate of St. George’s University School of Medicine, Dr. Walker is fluent in Spanish and culturally sensitive. She counsels her patients on health maintenance through lifestyle modifications and medications for diabetes management and prevention, obesity management, insulin resistance, metabolic syndrome management, and medical nutrition. Dr. Walker is fluent in Spanish and maintains membership in the American College of Physicians and the American Medical Association. She joins Atlantic Medical Group from Holyoke Health Center in Massachusetts and is a participating provider of the Atlantic Accountable Care Organization.
SPECIALTIES
Internal Medicine
AFFILIATIONS
Atlantic Medical Group
Overlook Medical Center
Where to see me
Insurance
Please contact the practice to confirm your health plan is accepted.
Education & Experience
TRAINING
BOARD CERTIFICATIONS
Patient Reviews
4.8
- 5.0Dec 31, 2024I can say that l was received with a warm heart at the Doctor 's office during my visit and I am satisfied . Thanks for their warm reception.
- 5.0Dec 29, 2024My experience has been great. Hospitality is great. The Care is amazing. Doctors are very hearing and compassionate, I appreciate the care and compassion.
- 5.0Dec 22, 2024Great experience! Kind and helpful people work at this office.
- 4.6Dec 8, 2024Very good experience
- 4.3Dec 5, 2024Good